For decades, Big Pharma has insisted that its outrageous price gouging is necessary to cover the costs of research and development. But a new report from a member of Congress should bust Big Pharma’s “R&D” myth once and for all.
From 2016 to 2020, the 14 top pharmaceutical companies spent $56 billion — that’s billion with a ‘b’ — MORE on stock buybacks and dividends than they did on research and development.
The jig is up. You spend more enriching your stockholders and yourselves than you do coming up with new medicines. Your days of holding us all hostage to your immoral price gouging are numbered.
Please share the petition with your network, and read our report now.
We must stop the billionaire Koch brothers from using their immense wealth to influence university research and spread their corporate-friendly ideology.